LEP expression was significantly decreased in invasive breast carcinoma (–16.434), breast phyllodes tumor (−21.654), mucinous breast carcinoma (–15.065), breast carcinoma (–15.496), and medullary breast carcinoma (–15.482) (Table 1). This evidence concerns the gene LEP and breast carcinoma.